https://scholars.lib.ntu.edu.tw/handle/123456789/621159
標題: | Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study | 作者: | Maurer, Marcus Giménez-Arnau, Ana Bernstein, Jonathan A CHIA-YU CHU Danilycheva, Inna Hide, Michihiro et al., |
關鍵字: | IgE; chronic spontaneous urticaria; ligelizumab; omalizumab; urticaria | 公開日期: | 2022 | 出版社: | WILEY | 卷: | 77 | 期: | 7 | 起(迄)頁: | 2175 | 來源出版物: | Allergy | 摘要: | Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately controlled with standard-of-care therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/621159 | ISSN: | 0105-4538 | DOI: | 10.1111/all.15175 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。